TWD 62.7
(2.96%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 589.98 Million TWD | 46.55% |
2022 | 402.59 Million TWD | 14.43% |
2021 | 351.81 Million TWD | 2.21% |
2020 | 344.19 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 653.79 Million TWD | 3.84% |
2024 Q1 | 629.62 Million TWD | 6.72% |
2023 Q4 | 589.98 Million TWD | 15.75% |
2023 FY | 589.98 Million TWD | 46.55% |
2023 Q3 | 509.7 Million TWD | 12.34% |
2023 Q2 | 453.72 Million TWD | 11.06% |
2023 Q1 | 408.52 Million TWD | 0.0% |
2022 FY | 402.59 Million TWD | 14.43% |
2022 Q4 | - TWD | 0.0% |
2021 FY | 351.81 Million TWD | 2.21% |
2020 FY | 344.19 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Biotech Corporation | 910.11 Million TWD | 35.174% |
GeneFerm Biotechnology Co., Ltd. | 282.53 Million TWD | -108.817% |
TTY Biopharm Company Limited | 3.36 Billion TWD | 82.487% |
Synmosa Biopharma Corporation | 3.62 Billion TWD | 83.737% |
Orient EuroPharma Co., Ltd. | 6.64 Billion TWD | 91.127% |
Center Laboratories, Inc. | 6.78 Billion TWD | 91.306% |
Tien Liang BioTech Co., Ltd. | 161.05 Million TWD | -266.334% |
Orient Pharma Co., Ltd. | 892.18 Million TWD | 33.871% |
InnoPharmax Inc. | 48.64 Million TWD | -1112.744% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 320.99 Million TWD | -83.801% |
Excelsior Biopharma Inc. | 472.87 Million TWD | -24.766% |
DV Biomed Co., Ltd. | 765.87 Million TWD | 22.965% |
Foresee Pharmaceuticals Co., Ltd. | 616.93 Million TWD | 4.367% |
Handa Pharmaceuticals, Inc. | 280.88 Million TWD | -110.049% |
UniPharma Co., Ltd. | 37.4 Million TWD | -1477.466% |
Anxo Pharmaceutical Co., Ltd. | 1.01 Billion TWD | 41.892% |
Alar Pharmaceuticals Inc. | 76.08 Million TWD | -675.392% |
Winston Medical Supply Co., Ltd. | 373.87 Million TWD | -57.804% |
Mercury Biopharmaceutical Corporation | 49.72 Million TWD | -1086.597% |
Bioray Biotech Co., Ltd | 108.75 Million TWD | -442.508% |
TSH Biopharm Corporation Limited | 133.62 Million TWD | -341.522% |